More recently, we identified ATIP expression in androgen-dependent (LNCaP) and androgen-independent (PC3) prostate cancer cells where we found ATIP1 to be a negative regulator of cell growth acting in concert with the AT2-receptor. This evidence concerns the gene AGTR2 and prostate carcinoma.